Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jan 10;17:145–154. doi: 10.2147/OPTH.S391527

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Fliney et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Categorical change in medications at 12 months compared with pre-op among the KDB and Trabectome groups.

Notes: The Kahook Dual Blade (KDB) group had a significantly greater number of eyes achieving a decrease in medications of at least 1 at 12 months following surgery compared with the Trabectome group. †Controlling for pre-op number of medications, intereye effects, and race/ethnicity.